Predicate & Substantial Equivalence Strategy
We evaluate whether a proposed predicate can withstand FDA's substantial equivalence analysis, then trace every meaningful technological difference into the evidence needed to support it.
What This Service Is
Predicate selection is not simply a search for the most commercially similar cleared device. A defensible predicate strategy must align intended use, technological characteristics and supporting performance evidence in a way that can sustain FDA review.
When It Is Needed
How We Assess Predicate Suitability
Our Regulatory Question
“For every meaningful difference, we ask: Does this difference raise a different question of safety or effectiveness? If not, what evidence is needed to demonstrate that the difference can be appropriately bridged?”
Defensible Argument & Evidence Plan
The objective is not to find the closest-looking device. It is to identify a predicate that supports a coherent, defensible regulatory argument and evidence plan.
Predicate Hierarchy
- Primary Predicate (Same intended use & tech)
- Reference Devices (Scientific support for tech differences)
- Multiple Predicates (When justified by FDA guidance)
Evaluate Your Predicate Options
Avoid 510(k) hold letters with an ironclad substantial equivalence strategy.
Discuss Predicate StrategyNeed to Verify Your Predicate Strategy?
Our senior FDA consultants will audit your predicate choices and substantial equivalence arguments.
